Biopsy Devices Market Analysis

Based on product type, the biopsy devices market is bifurcated into needles, vacuum-assisted devices, syringes, forceps and others, out of which, the highest market share is estimated to be held by vacuum assisted devices. This can be attributed to the ease of operability and availability in the market. The market is further segmented by application into breast biopsy, lung biopsy and other cancer treatments. Additionally, the effectiveness of the devices in locating the tumor and removal with surgical precision is high, making them the most preferred devices by surgeons. This is another factor estimated to contribute to the growth of the market.

Our in-depth analysis of the global market includes the following segments:

By Product Type	Needles Vacuum assisted devices Syringes Forceps others
By Application	Bone Biopsy Breast Biopsy Liver Biopsy Kidney Biopsy Prostate Biopsy Others
By Guidance	Computed Tomography (CT) Stereotactic Fluoroscopy Ultrasound MRI others
By End User	Hospitals Diagnostic and Imaging Centres Medical Clinics Others

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of biopsy devices is assessed at USD 2.76 billion.

Biopsy Devices Market size was valued at USD 2.61 billion in 2024 and is likely to cross USD 6.21 billion by 2037, registering more than 6.9% CAGR during the forecast period i.e., between 2025-2037.

North America industry is estimated to dominate majority revenue share by 2037, driven by presence of leading players in the region.

The major players in the market are ARGON MEDICAL, INRAD, Inc., Cook Group, Medtronic, FUJIFILM Holdings America Corporation, Cardinal Health, Boston Scientific Corporation, Becton, Dickinson and Company, B. Braun Melsungen AG, Olympus Corporation, and others.

Biopsy Devices Market Analysis